Menu

• Ask a Health Expert about CATHETER REMOVAL
• Post Your Side Effect related to CATHETER REMOVAL
• CATHETER REMOVAL and FDA Warnings
• CATHETER REMOVAL in Patients Wiki
• Report CATHETER REMOVAL in Drug Side Effect Survey

CATHETER REMOVAL side effect

What is CATHETER REMOVAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Imatinib Side Effects Report #5389846-3
Physician from UNITED KINGDOM reported IMATINIB MESYLATE problem on July 10, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5397366-5
IMATINIB MESYLATE problem was reported by a Physician from UNITED KINGDOM on July 18, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5389846-3
Physician from UNITED KINGDOM reported IMATINIB MESYLATE problem on July 10, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5397366-5
IMATINIB MESYLATE problem was reported by a Physician from UNITED KINGDOM on July 18, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.


Dianeal Side Effects Report #5777874-5
Health Professional from INDIA reported DIANEAL problem on June 09, 2008. Female patient, 60 years of age, weighting 121.3 lb, was diagnosed with peritoneal dialysis and was treated with DIANEAL. After drug was administered, patient experienced the following problems/side effects: catheter removal, fungal peritonitis, pyrexia, . DIANEAL dosage: unknown. Patient recovered.

Imatinib Side Effects Report #5430440-3
IMATINIB MESYLATE problem was reported by a Physician from UNITED KINGDOM on Aug 24, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5392012-9
Health Professional from UNITED STATES reported CETUXIMAB problem on July 17, 2007. Female patient, weighting 142.2 lb, was diagnosed with laryngeal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter removal, staphylococcal infection, . CETUXIMAB dosage: 250MG/M2 IV QW. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5392012-9
CETUXIMAB problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Female patient, weighting 142.2 lb, was diagnosed with laryngeal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter removal, staphylococcal infection, . CETUXIMAB dosage: 250MG/M2 IV QW. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Myfortic Side Effects Report #5654677-3
Physician from GERMANY reported MYFORTIC problem on Feb 27, 2008. Male patient, 53 years of age, was diagnosed with renal transplant and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, blood creatinine increased, catheter removal, epididymal infection, femoral nerve palsy, hydronephrosis, nephrostomy, post procedural infection, transplant rejection, . MYFORTIC dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.


Myfortic Side Effects Report #5575376-2
MYFORTIC problem was reported by a Physician from GERMANY on Dec 20, 2007. Male patient, 53 years of age, was diagnosed with renal transplant and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, blood creatinine increased, catheter removal, epididymal infection, femoral nerve palsy, hydronephrosis, nephrostomy, post procedural infection, transplant rejection, . MYFORTIC dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.